incobotulinumtoxinA
Showing 1 - 25 of 104
Overactive Bladder Syndrome Trial run by the Walter Reed National Military Medical Center (Xeomin 100 UNT Injection, Botox 100
Recruiting
- Overactive Bladder Syndrome
- Xeomin 100 UNT Injection
- Botox 100 UNT Injection
-
Bethesda, MarylandWalter Reed National Military Medical Center
Sep 5, 2023
Long-term Clinical Response to BoNT in Cervical Dystonia
Not yet recruiting
- Cervical Dystonia
- CC BoNT/A
- +3 more
-
Düsseldorf, North Rhine-Westphalia, GermanyDüsseldorf University Hospital
May 22, 2023
Chronic Migraine Trial in Jacksonville (IncobotulinumtoxinA (XEOMIN®), OnabotulinumtoxinA (BOTOX®))
Not yet recruiting
- Chronic Migraine
- IncobotulinumtoxinA (XEOMIN®)
- OnabotulinumtoxinA (BOTOX®)
-
Jacksonville, North CarolinaNaval Medical Center Camp Lejeune
Oct 25, 2022
Spastic Cerebral Palsy Trial (IncobotulinumtoxinA 100 UNT [Xeomin])
Not yet recruiting
- Spastic Cerebral Palsy
- IncobotulinumtoxinA 100 UNT [Xeomin]
- (no location specified)
Apr 14, 2022
Thoracic Outlet Syndrome, Whiplash Injuries Trial in Halifax (IncobotulinumtoxinA 100 UNT)
Not yet recruiting
- Thoracic Outlet Syndrome
- Whiplash Injuries
- IncobotulinumtoxinA 100 UNT
-
Halifax, Nova Scotia, CanadaPrivate Office
Sep 9, 2022
Longitudinal Evaluation and Real-world Evidence of NT201
Not yet recruiting
- Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face
- IncobotulinumtoxinA
- (no location specified)
Jan 24, 2022
N/A, as no Specific Medical Condition Will be Treated Trial in Hamburg (IncobotulinumtoxinA)
Active, not recruiting
- N/A, as no Specific Medical Condition Will be Treated
- IncobotulinumtoxinA
-
Hamburg, GermanyMerz Investigational Site #0490385
Jan 31, 2023
Trigeminal Neuralgia Trial in Philadelphia (Incobotulinumtoxina, Placebo Comparator)
Terminated
- Trigeminal Neuralgia
- Incobotulinumtoxina
- Placebo Comparator
-
Philadelphia, PennsylvaniaJefferson Headache Center at Thomas Jefferson University
Nov 29, 2021
Degenerative Rotator Cuff Disease Trial (The investigational medicinal product is incobotulinumtoxinA (XEOMIN®)., PLACEBO)
Not yet recruiting
- Degenerative Rotator Cuff Disease
- The investigational medicinal product is incobotulinumtoxinA (XEOMIN®).
- PLACEBO
- (no location specified)
Sep 15, 2022
Enlarged Pores, Sebum Production Trial in Los Angeles, Nashville (NT 201, Placebo)
Recruiting
- Enlarged Pores
- Sebum Production
- NT 201
- Placebo
-
Los Angeles, California
- +1 more
Mar 24, 2023
Platysma Prominence Trial in United States (NT 201, NT 201 Placebo)
Recruiting
- Platysma Prominence
- NT 201
- NT 201 Placebo
-
Washington, District of Columbia
- +3 more
Mar 23, 2023
Cosmetic Techniques Trial in Philadelphia (Onabotulinumtoxina for Injection, Abobotulinumtoxina for Injection,
Recruiting
- Cosmetic Techniques
- Onabotulinumtoxina for Injection
- +3 more
-
Philadelphia, Pennsylvania
- +1 more
Jun 27, 2022
Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
Not yet recruiting
- Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
- IncobotulinumtoxinA
- Placebo
- (no location specified)
Oct 13, 2023
Healthy Participants Trial in Manchester (Botulinum toxin type A)
Completed
- Healthy Participants
- Botulinum toxin type A
-
Manchester, United KingdomMac Research Clinical research Unit
Jun 14, 2022
Pancreatic Carcinoma Trial in Portland (Botulinum Toxin Type A)
Not yet recruiting
- Pancreatic Carcinoma
- Botulinum Toxin Type A
-
Portland, OregonOHSU Knight Cancer Institute
May 16, 2022
Glabellar Frown Lines Trial in Encino, Los Angeles (IncobotulinumtoxinA)
Not yet recruiting
- Glabellar Frown Lines
- IncobotulinumtoxinA
-
Encino, California
- +1 more
Mar 30, 2022
Peripheral Neuropathy Due to Chemo Trial in Milwaukee (IncobotulinumtoxinA (Xeomin®, Merz) (INA), Normal saline)
Recruiting
- Peripheral Neuropathy Due to Chemotherapy
- IncobotulinumtoxinA (Xeomin®, Merz) (INA)
- Normal saline
-
Milwaukee, WisconsinFroedtert Hospital
Dec 21, 2021
Rosacea Trial in Chicago (IncobotulinumtoxinA, Bacteriostatic saline)
Completed
- Rosacea
- IncobotulinumtoxinA
- Bacteriostatic saline
-
Chicago, IllinoisDeNova Research
Sep 14, 2020
Glabellar Lines Trial in Canada, Germany, United States (IncobotulinumtoxinA (Xeomin) (20 units))
Completed
- Glabellar Lines
- IncobotulinumtoxinA (Xeomin) (20 units)
-
Los Angeles, California
- +24 more
Mar 8, 2021
Cerebral Palsy, Spasticity Trial in Worldwide (IncobotulinumtoxinA (8 Units per kg body weight), IncobotulinumtoxinA (6 Units
Completed
- Cerebral Palsy
- Spasticity
- IncobotulinumtoxinA (8 Units per kg body weight)
- +2 more
-
Gulf Breeze, Florida
- +31 more
Aug 3, 2021
Lower Limb Spasticity Due to Cerebral Palsy Trial in Worldwide (IncobotulinumtoxinA (16 Units per kg body weight),
Completed
- Lower Limb Spasticity Due to Cerebral Palsy
- IncobotulinumtoxinA (16 Units per kg body weight)
- +2 more
-
Graz, Austria
- +52 more
Aug 3, 2021
Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines) Trial in
Completed
- Moderate to Severe Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines, and Lateral Canthal Lines)
- NT 201
- Placebo
-
Bad Soden, Germany
- +11 more
Jul 25, 2022
Focal Hand Dystonia Trial in Switzerland (Xeomin, Placebo - Concentrate)
Unknown status
- Focal Hand Dystonia
- Xeomin
- Placebo - Concentrate
-
Berne, Switzerland
- +4 more
Apr 28, 2020